APA (7th ed.) Citation

Rasche, L., Braendlein, S., Duell, J., Knop, S., Dubljevic, V., Rosenwald, A., . . . Topp, M. S. (2013). A Monoclonal IgM Antibody With Specificity To Heat Shock Protein GRP78/BIP Shows Anti- Myeloma Activity In Vitro and In Vivo, Synergy In Combination With Lenalidomide and Safety In a Pilot Phase I Study. Blood, 122(21), 3213. https://doi.org/10.1182/blood.V122.21.3213.3213

Chicago Style (17th ed.) Citation

Rasche, Leo, Stephanie Braendlein, Johannes Duell, Stefan Knop, Valentina Dubljevic, Andreas Rosenwald, Hermann Einsele, and Max S. Topp. "A Monoclonal IgM Antibody With Specificity To Heat Shock Protein GRP78/BIP Shows Anti- Myeloma Activity In Vitro and In Vivo, Synergy In Combination With Lenalidomide and Safety In a Pilot Phase I Study." Blood 122, no. 21 (2013): 3213. https://doi.org/10.1182/blood.V122.21.3213.3213.

MLA (9th ed.) Citation

Rasche, Leo, et al. "A Monoclonal IgM Antibody With Specificity To Heat Shock Protein GRP78/BIP Shows Anti- Myeloma Activity In Vitro and In Vivo, Synergy In Combination With Lenalidomide and Safety In a Pilot Phase I Study." Blood, vol. 122, no. 21, 2013, p. 3213, https://doi.org/10.1182/blood.V122.21.3213.3213.